Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01141101 · ClinicalTrials.gov registry record

Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus

A clinical trial of Methicillin-resistant Staphylococcus Aureus, sponsored by Boston Medical Center.

Completed
Registry status
100
Enrollment target
1
Study location

NCT01141101: Completed study of Methicillin-resistant Staphylococcus Aureus, sponsored by Boston Medical Center.

NCT01141101 is a study of Methicillin-resistant Staphylococcus Aureus that has completed, run by Boston Medical Center. The registered enrollment target is 100 participants, below the 15,885-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01141101, a study of Methicillin-resistant Staphylococcus Aureus, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) colonization and infections have been increasing in the general population, including the pediatric population. It has been reported that MRSA colonization persists for up to four years, and therefore the youngest pediatric patients, specifically those who are less than 2 years of age, have a high risk of prolonged colonization during a period of time when they are susceptible to significant skin and soft tissue infections (SSTIs) attributable to MRSA. Once prolonged colonization takes place, recurrent SSTIs are commonplace, resulting in substantial morbidity and in some cases mortality, as well as a significant cost to the healthcare system. Individuals colonized with MRSA have an increased risk of developing MRSA infections, which range from mild disease, such as carbuncles, to severe infections, such as necrotizing pneumonia and toxic shock syndrome. The prevalence of severe MRSA infections is also greatest in neonates and infants, where increased MRSA colonization has been observed. In the early infant period, the most common manifestation of MRSA disease is pustular skin lesions, which affect approximately 5% of the general population, with MRSA-colonization being a major risk factor for this disease. Moreover, the prevalence of pustular disease is increasing in the general population, and there are numerous case reports of invasive, life-threatening MRSA disease in the early infant period. Corresponding to the increasing prevalence in the community, the carriage of MRSA in pregnant women has also escalated, and vaginal carriage is significant in pregnant women. As an analogy, maternal vaginal Group B Streptococcal (GBS) colonization is the major risk for infant colonization regardless of whether early or late neonatal colonization or disease occurs. It is quite feasible that vaginal MRSA carriage predisposes newborns to colonization during the birthing process; however, this mechanism has no

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2010-06
Est. Completion 2012-06
Boston Medical Center

253 total trials

What the finished NCT01141101 record still lists

NCT01141101 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 15,885-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Methicillin-resistant Staphylococcus Aureus appearing as the primary indexed condition, and to 0 interventions.

NCT01141101 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01141101 about?

NCT01141101 is a clinical study titled "Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus". The prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) colonization and infections have been increasing in the general population, including the pediatric population. It has been reported that MRSA colonization persists for up to four years, and therefore the youngest pediatric patient...

What is the current status of trial NCT01141101?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2010-06. Estimated completion is 2012-06.

What conditions does trial NCT01141101 study?

This clinical trial studies the following conditions: Methicillin-resistant Staphylococcus Aureus.

Who is sponsoring clinical trial NCT01141101?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01141101 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Methicillin-resistant Staphylococcus Aureus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01141101, the US trial registry maintained by the National Library of Medicine. NCT01141101 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.